EXAS vs NCLH · rev $2.76B vs P/E 16, rev $4.97B
EXACT Sciences Corporation (EXAS) versus Norwegian Cruise Line Holdings Ltd (NCLH) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
EXAS currently screens at market cap $20.03B. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Not investment advice. Open the EXAS and NCLH stock pages for the full models.
Not investment advice.